THYROID MEDICINE RECALL
Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients need to know
Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should know
Levothyroxine recalled nationwide by FDA; Earlier studies claim over 20 million Americans are 'unnecessarily' taking this thyroid medication
How to get IPO-ready and ride the primary market boomAfter a dry patch of almost a decade, the IPO floodgates have opened up. If 2016 was good — 88 companies raised Rs 26,000 crore — 2017 prom...23 Apr, 2017, 07.21 AM IST
Load More